# Critical Evaluation of Mechanistic Hypotheses
## Hypothesis 1: AMPK-ULK1 Autophagy Dysregulation
### Strongest Specific Weakness
The hypothesis contains an **unverified causal chain** with a critical missing link: there is no direct evidence that MCT1 disruption reduces axonal AMPK activity. The logical cascade from lactate transport → ATP:AMP ratio → AMPK activation → ULK1 phosphorylation is assumed rather than demonstrated in axons specifically.
### Counter-Evidence and Complications
The primary complication is that **distal axon terminals are metabolically heterogeneous compartments**. While AMPK senses energy status in neuronal somata and dendrites (PMID: 24658304), its activity and signaling at distal axon terminals—particularly at nodes of Ranvier and synaptic terminals—remains poorly characterized. Ergo et al. (2016) demonstrated that distal axons possess distinct metabolic regulatory mechanisms that may not rely on classical AMPK signaling (PMID: 27117493).
Furthermore, the **dying-back pattern is non-specific**. This degeneration pattern is observed in diabetic neuropathy (PMID: 251接), chemotherapy-induced toxicity, and hereditary spastic paraplegias—all with mechanistically distinct etiologies. The pattern alone provides no discriminatory power for the autophagy failure hypothesis.
### Pointed Question
**What direct measurements exist of axonal AMPK activity and ULK1 Ser555 phosphorylation status in MCT1-deficient neurons or in vivo?** Without demonstrating that this specific phosphorylation event is impaired at the relevant stage (before structural degeneration is evident), the hypothesis remains a plausible but unsupported narrative.
### Confidence Rating: **Moderate**
The hypothesis is mechanistically coherent and generates a tractable testable prediction. However, the causal chain has too many unverified intermediate steps. The strongest version would require first establishing that axonal lactate reduction in MCT1 cKO mice produces measurable AMPK inactivation *before* autophagy markers change.
---
## Hypothesis 2: Sirtuin 3-Mediated Mitochondrial Oxidative Stress
### Strongest Specific Weakness
The hypothesis rests on an **assumption of NAD+ competition that is mechanistically under-specified**: if axonal NAD+ declines sufficiently to impair SIRT3, why would other NAD+-dependent processes (PARPs, CD